thromboplastin has been researched along with Thyroid-Neoplasms* in 3 studies
3 other study(ies) available for thromboplastin and Thyroid-Neoplasms
| Article | Year |
|---|---|
Heparanase, galectin-3, and tissue factor mRNA are expressed in benign neoplasms of the thyroid.
Heparanase, galectin-3, and tissue factor (TF) are overexpressed in solid malignant thyroid tumors. We studied their expression in multinodular goiters (MNGs).. Thyroid tissue specimens from 15 MNGs were obtained during surgery. mRNA expression for galectin-3, heparanase, and TF was assessed by RT-PCR.. Isolated expressions of heparanase and galectin- 3 mRNA were expressed in 2 and 4 of the 15 MNGs, respectively; 8/15 MNGs were positive for both heparanase and galectin-3. TF mRNA was found in all MNG specimens.. Galectin-3, heparanase, and TF RNA expression is prevalent in MNGs. Further studies will be needed to determine the prognostic significance of these findings. Topics: Biomarkers, Tumor; Female; Galectin 3; Glucuronidase; Goiter, Nodular; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Thyroid Neoplasms | 2003 |
Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
In this study we have looked for differences in coagulation parameters before and after surgical removal of benign or malignant tumours. A striking increase in thromboplastin activity of the blood monocytes was seen 1 d after surgery. This paralleled a fall in factor VII activity. At the same time, the sensitivity of the blood monocytes to stimulation by endotoxin increased significantly. We propose from this study that monocyte thromboplastin may be a postoperative thrombogenic factor. Increased levels of factor VIII and fibrinogen 2-3 d postoperatively were found, probably caused by inflammation reactions induced by the surgery. No difference in coagulation parameters could be demonstrated between patients with benign, noninvasive lesions and patients with invasive, carcinomatous lesions. Topics: Blood Coagulation; Breast Neoplasms; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Male; Monocytes; Neoplasms; Postoperative Period; Prostatic Hyperplasia; Thromboplastin; Thyroid Neoplasms; Time Factors; Urinary Bladder Neoplasms | 1984 |
Anti-thyroid drugs--a cause of liability to bleeding during thyroid surgery.
Topics: Adenoma; Antithyroid Agents; Drug Synergism; Fibrinolysis; Goiter; Hematoma; Hemorrhage; Humans; Plasminogen; Postoperative Complications; Preoperative Care; Thromboplastin; Thyroid Gland; Thyroid Neoplasms | 1971 |